Zydus Wellness Opens Special Window for Physical Securities Transfer and Dematerialisation

2 min read     Updated on 31 Mar 2026, 06:10 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Zydus Wellness Limited has opened a special window facility from February 5, 2026 to February 4, 2027 for transfer and dematerialisation of physical securities purchased before April 1, 2019, following SEBI Circular dated January 30, 2026. Securities transferred during this period will be credited in demat mode only and subject to one-year lock-in. Eligible investors must submit required documents to RTA MUFG Intime India Private Limited before February 4, 2027.

powered bylight_fuzz_icon
36463241

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has announced the implementation of a special window facility for the transfer and dematerialisation of physical securities, in compliance with recent regulatory guidelines. The company published notices in both English and Gujarati editions of Financial Express on March 30, 2026, informing stakeholders about this important development.

SEBI Circular Implementation

The special window facility has been established pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated January 30, 2026. This regulatory directive aims to facilitate the processing of physical securities that have remained in physical form for an extended period.

Parameter: Details
Facility Duration: February 5, 2026 to February 4, 2027
Eligible Securities: Purchased/sold prior to April 1, 2019
Transfer Mode: Mandatory demat credit only
Lock-in Period: One year from transfer registration

Scope and Eligibility

The special window covers physical securities that were purchased or sold prior to April 1, 2019. Additionally, the facility extends to transfer requests that were previously rejected, returned, or not processed due to deficiencies in documents, procedural issues, or other reasons.

During the special window period, all securities transferred will be mandatorily credited to the transferee exclusively in demat mode. These securities will be subject to a lock-in period of one year from the date of transfer registration, during which they cannot be transferred, lien-marked, or pledged.

Application Process

Eligible investors seeking to utilize this facility must submit the required documents as specified in the SEBI Circular to the company's Registrar and Share Transfer Agent. The documents must be complete in all respects and submitted before the deadline of February 4, 2027.

Contact Details: Information
RTA: MUFG Intime India Private Limited
Address: 5th Floor, 506 to 508, Amarnath Business Centre-I
Location: Nr. St. Xavier's College Corner, Off C G Road, Ellisbridge
City: Ahmedabad - 380006
Deadline: February 4, 2027

Contact Information

For additional details and assistance, investors can reach out through multiple channels. The company has provided dedicated contact points for investor queries and support throughout the application process.

Company Contact:

RTA Contact:

The notice was signed by Nandish P. Joshi, Company Secretary and Compliance Officer (Membership No. ACS39036), and dated March 28, 2026, from Ahmedabad. This initiative represents Zydus Wellness Limited's commitment to regulatory compliance and facilitating shareholder services in accordance with SEBI guidelines.

How will the mandatory demat conversion and one-year lock-in period impact Zydus Wellness's trading liquidity and share price volatility?

What percentage of Zydus Wellness's total shareholding is expected to be affected by this physical-to-demat conversion process?

Could this SEBI initiative trigger similar special window facilities across other listed companies with significant physical shareholdings?

like20
dislike

Zydus Wellness Subsidiary Receives ₹6.30 Million GST Penalty Order from CGST Commissionerate

1 min read     Updated on 30 Mar 2026, 11:32 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Zydus Wellness Limited's wholly owned subsidiary, Zydus Wellness Products Limited, has received a GST penalty order of ₹6.30 million along with applicable interest from the CGST Commissionerate in Ghaziabad for alleged less reversal of input tax credit covering financial years 2019-20 and 2020-21. The company received the order on March 29, 2026, and has stated that it will assess the next course of action as the order is appealable. The company maintains that there is no immediate impact on its financial or operational activities, with any impact limited to the final tax liability that may be determined along with interest and penalty.

powered bylight_fuzz_icon
36439375

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has disclosed to stock exchanges that its wholly owned subsidiary received a significant GST penalty order from tax authorities. The regulatory filing, made under SEBI Listing Regulations, reveals important details about the tax proceedings and the company's response strategy.

GST Penalty Details

Zydus Wellness Products Limited (ZWPL), the wholly owned subsidiary of Zydus Wellness Limited, received an order in Form GST DRC-07 from the Office of The Assistant Commissioner, Division-II, CGST Commissionerate, Ghaziabad, Uttar Pradesh. The order was received on March 29, 2026 at 5:04 p.m.

Parameter: Details
Penalty Amount: ₹6.30 million
Additional Charges: Applicable interest
Financial Years Covered: 2019-20 and 2020-21
Issuing Authority: Assistant Commissioner, Division-II, CGST Commissionerate, Ghaziabad, UP

Nature of Alleged Violation

The CGST authorities have alleged less reversal of input tax credit under section 17 of The Central Goods and Service Tax Act, 2017 read with rule 42 of Central Goods and Service Tax Rules, 2017. The penalty has been imposed under the provisions of section 74(9) read with section 122(2)(b) of the CGST Act.

Company's Response and Impact Assessment

Zydus Wellness Limited has indicated that the order is currently appealable and ZWPL will make an assessment for the next course of action. The company has provided a clear stance on the potential impact of this development.

Impact Analysis:

  • No impact on financial, operational or other activities of the Company or ZWPL due to this order
  • The impact will be limited to the final tax liability as may be ascertained along with interest and penalty, if any
  • The company is evaluating its legal options given the appealable nature of the order

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with clause no. 20 of Para A of Part A of Schedule III of the SEBI Listing Regulations, along with relevant SEBI Master Circulars. This demonstrates the company's commitment to maintaining transparency with stakeholders regarding material developments that could affect its operations.

Will this GST penalty prompt increased scrutiny of Zydus Wellness's tax compliance across other subsidiaries and jurisdictions?

How might this tax dispute affect Zydus Wellness's credit rating and borrowing costs if the appeal is unsuccessful?

Could this case signal broader GST enforcement trends that may impact other pharmaceutical and wellness companies?

like17
dislike

More News on Zydus Wellness